DSRLF
DiaSorin S.p.A.
Set alert
- YTD
- +20.99%
- 1 year
- -1.99%
- Open
- 92.00
- Prev close
- 92.00
- Mkt cap
- 4.53B
- Vol
- 226
- Avg vol
- 9
- EPS
- 3.17
- P/E
- 29.02
More statistics
- Low
- 92.00
- High
- 92.00
News
3 weeks ago defenseworld.net
DiaSorin (OTCMKTS:DSRLF) Shares Down 1.7% – Should You Sell?
Shares of DiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) traded down 1.7% during mid-day trading on Friday. The stock traded as low as $84.00 and last traded at $84.00. 5 shares traded hands…
3 months ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript
DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript
5 months ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q1 2026 Earnings Call Transcript
DiaSorin S.p.A. (DSRLF) Q1 2026 Earnings Call Transcript
6 months ago defenseworld.net
Head to Head Contrast: Perrigo (NYSE:PRGO) and DiaSorin (OTCMKTS:DSRLF)
DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Perrigo (NYSE: PRGO - Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the…
7 months ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q4 2025 Earnings Call Transcript
DiaSorin S.p.A. (DSRLF) Q4 2025 Earnings Call Transcript
9 months ago defenseworld.net
Head-To-Head Survey: Abbott Laboratories (NYSE:ABT) vs. DiaSorin (OTCMKTS:DSRLF)
DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Abbott Laboratories (NYSE: ABT - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based…
10 months ago defenseworld.net
Head-To-Head Review: IM Cannabis (NASDAQ:IMCC) versus DiaSorin (OTCMKTS:DSRLF)
DiaSorin (OTCMKTS:DSRLF - Get Free Report) and IM Cannabis (NASDAQ: IMCC - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on…
11 months ago seekingalpha.com
Invesco International Small-Mid Company Fund Q3 2025 Portfolio Positioning
Invesco International Small-Mid Company Fund added six new positions and exited 11 positions during the quarter. We are benchmark independent, bottom-up investors, focusing on company fundamentals…
1 year ago seekingalpha.com
DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate
DiaSorin's 2024 revenue grew by 3%, with an underlying increase of 7%, and net profit rose to 188.1M EUR, reflecting a 17% EPS increase. The company generated strong free cash flow of 191M EUR,…
1 year ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2024 Results Conference Call March 14, 2025 12:30 PM ET Company Participants Carlo Rosa - CEO Piergiorgio Pedron - CFO Conference Call Participants Kavya Deshpande -…
1 year ago reuters.com
Italy's DiaSorin ex-Covid revenue in line with guidance
Italian medical diagnostics group DiaSorin on Friday reported a 3% rise in 2024 revenue, citing dampened demand for its products with a milder Flu season compared to the previous year.
2 years ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2024 Earnings Conference Call July 29, 2024 11:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
2 years ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
2 years ago reuters.com
Diasorin 2023 revenue drops 14%, in line with guidance; shares fall
Italian medical diagnostic group Diasorin on Friday reported a double-digit drop in revenue for 2023, in line with its revenue guidance for the year, but shares dropped as much as 7.3%.
2 years ago zacks.com
New Strong Sell Stocks for January 29th
T, DSRLF and HAFC have been added to the Zacks Rank #5 (Strong Sell) List on January 29, 2023.
2 years ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q3 2023 Earnings Conference Call November 3, 2023 11:30 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
3 years ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q2 2023 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
3 years ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2022 Earnings Conference Call March 27, 2023 9:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…
3 years ago seekingalpha.com
DiaSorin: Overvalued Italian Healthcare Company
DiaSorin S.p.A. is an Italian healthcare company that develops, produces, and sells reagent kits and analyzer instruments mostly used to detect patients' diseases. DiaSorin benefited from the…
4 years ago seekingalpha.com
DiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2022 Earnings Conference Call August 3, 2022 9:00 AM ET Company Participants Carlo Rosa - Chief Executive Officer Piergiorgio Pedron - Chief Financial Officer…